Tuesday, December 13, 2022

Amgen/Horizon: swoop on rare disease specialist will push up debt load

The strategic logic of buying Horizon is hard to fault. But good assets do not come cheap

from News Feed https://ift.tt/O9Ma6bc
via IFTTT
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)